Italy Peptide Receptor Radionuclide Therapy Market Poised for Significant Growth

Peptide Receptor Radionuclide Therapy Market


Peptide receptor radionuclide therapy employs radiolabelled peptides that selectively target overexpressed peptide receptors on cancer cells for imaging and targeted radionuclide therapy of tumours. These receptor targeting peptides allow delivery of radionuclides specifically to cancer tissues with high receptor densities.

The global Italy Peptide Receptor Radionuclide Therapy Market is estimated to be valued at US$ 681.79 Mn in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increased prevalence of cancer and rising demand for innovative treatment options are propelling the uptake of peptide receptor radionuclide therapy. According to the Italian National Cancer Institute, cancer constituted the second leading cause of death in Italy in 2021, accounting for over 182,000 new cancer cases and 79,000 cancer deaths. Peptide receptor radionuclide therapy provides an efficacious targeted radiotherapy for inoperable and metastatic neuroendocrine tumors with high receptor densities. Its higher efficacy and improved safety over traditional chemotherapy and fewer side effects are increasing its adoption over conventional cancer treatment alternatives in Italy.

Segment Analysis
The Italy peptide receptor radionuclide therapy market is dominated by neuroendocrine tumors and gastroenteropancreatic neuroendocrine tumors sub segment. This sub segment accounts for over 30% of the total market share owing to increasing incidence rates of neuroendocrine tumors in Italy. The neuroendocrine tumors are the most frequently occurring in lungs, gastrointestinal tract and breasts. Moreover, peptide receptor radionuclide therapy is emerging as a safe and effective therapeutic option for inoperable or metastatic neuroendocrine tumors.

Key Takeaways
The global Italy peptide receptor radionuclide therapy market is expected to witness high growth during the forecast period. Italy Peptide Receptor Radionuclide Therapy Market Size is estimated to be valued at US$ 681.79 Mn in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2024 to 2031.

North America region dominates the regional analysis currently and is poised to grow at an exponential rate owing to increasing prevalence of neuroendocrine tumors and favorable reimbursement policies.

Key players operating in the Italy peptide receptor radionuclide therapy are Bayer AG, Novartis AG, Advanced Accelerator Applications, Progenics Pharmaceuticals, Inc. Blue Earth Diagnostics Limited. Regional analysis related content comprises Bayer AG is the dominant player in Italy Peptide Receptor Radionuclide Therapy market with over 40% value share owing to its established product portfolio and strong distribution network across Italy. Novartis is the second largest player with product Lutathera and focuses on clinical trials for new indications.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Global Methyl & Ethyl Chloroacetate Market Is Expected To Register A Cagr Of 7.9% In Terms Of Revenue Over The Forecast Period (2019-2027)

Image
  Methyl chloroacetate is a colourless liquid with a pungent odour that is used as a dyestuff, medicine, and pesticide intermediate. Methyl chloroacetate has several advantages, including a precise pH value, excellent purity, precise composition, and a longer shelf life. Ethyl chloroacetate is a clear liquid with a strong, fruity odour that is used in the production of dyes, chemical compounds, and other products. Ethyl chloroacetate's benefits include a balanced composition, stable chemical and physical properties, and optimum purity.   The global methyl & ethyl chloroacetate market was valued at US$ 760.6 Mn in 2018, and is expected to register a CAGR of 7.9% in terms of revenue over the forecast period (2019-2027), to reach US$ 1,562.8 Mn by 2027.   Over the forecast period, the global Methyl & Ethyl Chloroacetate Market is expected to grow significantly. The various benefits offered by methyl and ethyl chloroacetate have led to an increase in their use in end-use indus
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more